Revisions of 'Primary cutaneous gamma-delta T-cell lymphoma'
-
Revision 12 - created 7 months ago by Calum Worsley - view changesetDate: 2023-10-10 09:03:07 UTC Disclosures:
At the time the revision was created Calum Worsley had no financial relationships to ineligible companies to disclose.
View Calum Worsley's current disclosures Reviewed by: Joachim Feger -
Revision 11 - created 8 months ago by Ryan Thibodeau - view changesetDate: 2023-10-01 23:30:51 UTC Disclosures:
At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.
View Ryan Thibodeau's current disclosures Reviewed by: Calum Worsley -
Revision 10 - created 8 months ago by Arlene Campos - view changesetDate: 2023-09-22 01:32:20 UTC Disclosures:
At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosures Reviewed by: Ryan Thibodeau -
Revision 9 - created 8 months ago by Peter Badrov - view changesetDate: 2023-09-21 16:50:30 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Henry Knipe -
Revision 8 - created 8 months ago by Peter Badrov - view changesetDate: 2023-09-11 03:11:01 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Joachim Feger -
Revision 7 - created 9 months ago by Henry Knipe - view changesetDate: 2023-09-07 05:38:39 UTC Disclosures:
At the time the revision was created Henry Knipe had the following disclosures:
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Henry Knipe's current disclosures Reviewed by: Yahya Baba -
Revision 6 - created 9 months ago by Peter Badrov - view changesetDate: 2023-09-07 00:30:56 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Henry Knipe -
Revision 5 - created 9 months ago by Peter Badrov - view changesetDate: 2023-09-02 20:58:38 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Henry Knipe -
Revision 4 - created 9 months ago by Peter Badrov - view changesetDate: 2023-08-29 21:00:58 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Henry Knipe -
Revision 3 - created 9 months ago by Peter Badrov - view changesetDate: 2023-08-29 20:01:17 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Henry Knipe -
Revision 2 - created 9 months ago by Peter Badrov - view changesetDate: 2023-08-29 19:30:22 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Arlene Campos -
Revision 1 - created 9 months ago by Peter Badrov - view changesetDate: 2023-08-29 18:13:46 UTC Disclosures:
At the time the revision was created Peter Badrov had no financial relationships to ineligible companies to disclose.
View Peter Badrov's current disclosures Reviewed by: Arlene Campos
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.